Physician profile
Eric N Bowman
NPI 1801153622
$6,391.01
in general payments reported to CMS, 2019-2025
10 companies · $1,895 in 2025
The $1,895 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,139 · 2020: $1,523 · 2021: $1,228 · 2022: $57.64 · 2023: $232 · 2024: $317 · 2025: $1,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,398 · Food and Beverage: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,398.36 |
| Food and Beverage | $1,045.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $4,118.43 | 2019-2024 | |
| Arthrex, INC. | $1,054.90 | 2025 | |
| Music City Medical Technologies, LLC | $715.26 | 2025 | |
| Ossur Americas, INC. | $164.32 | 2024 | Miami J |
| Bone Support INC. | $124.43 | 2025 | Ceramentbone Void Filler, Cerament G |
| Zimmer Biomet Holdings, INC. | $99.91 | 2019 | |
| Pacira Therapeutics, INC. | $44.92 | 2019 | |
| Depuy Synthes Sales INC. | $32.50 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.14 | 2022 | |
| Currax Pharmaceuticals LLC | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.